BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™in patients with pulmonary arterial hypertension.
Saved in:
| Title: | BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™in patients with pulmonary arterial hypertension. |
|---|---|
| Authors: | Spikes, Leslie A.1 LSpikes@kumc.edu, Bajwa, Abubakr A.2, Burger, Charles D.3, Desai, Sapna V.4, Eggert, Michael S.5, El‐Kersh, Karim A.6, Fisher, Micah R.7, Johri, Shilpa8, Joly, Joanna M.9, Mehta, Jinesh10, Palevsky, Harold I.11, Ramani, Gautam V.12, Restrepo‐Jaramillo, Ricardo13, Sahay, Sandeep14, Shah, Trushil G.15, Chunqin Deng16, Miceli, Melissa17, Smith, Peter16, Shapiro, Shelley M.18 |
| Source: | Pulmonary Circulation. Apr2022, Vol. 12 Issue 2, p1-14. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
